Bromonordiazepam CAS: 2894-61-3

CAS NO: 2894-61-3
Bromonordiazepam
Chemical Name: Bromonordiazepam
Molecular Formula: C15H11BrN2O
Formula Weight: 315.16
CAS No.: 2894-61-3
Description Review
Description

Bromonordiazepam is a benzodiazepine derivative that belongs to the class of psychoactive drugs. It is also known as N-desalkylflurazepam, Ro5-3448, and Bromazepam. This compound acts as a sedative-hypnotic agent, anxiolytic, and anticonvulsant. The chemical formula for Bromonordiazepam is C15H11BrN2O, and it has a molecular weight of 324.16 g/mol. The CAS number for this compound is 2894-61-3.

Top Ten Keywords and Synonyms

  1. Benzodiazepine
  2. Sedative-hypnotic
  3. Anxiolytic
  4. Anticonvulsant
  5. Ro5-3448
  6. N-desalkylflurazepam
  7. Bromazepam
  8. GABA receptor
  9. Prescription drug
  10. Central nervous system depressant

Chemical Structure and Health Benefits of Bromonordiazepam

The health benefits of Bromonordiazepam are related to its ability to act on the central nervous system (CNS). This compound works by binding to the gamma-aminobutyric acid (GABA) receptor in the brain, which increases the inhibitory effects of GABA neurotransmitters. This leads to a decrease in neuronal activity, resulting in sedation, relaxation, and anxiety relief.

Bromonordiazepam is commonly prescribed for the treatment of anxiety disorders and insomnia. It is also used as an adjunctive therapy for seizures and alcohol withdrawal symptoms. This compound is effective in reducing the severity and frequency of panic attacks, phobias, and generalized anxiety disorder. In addition, Bromonordiazepam can induce sleep and improve sleep continuity, making it a useful treatment option for individuals with insomnia.

Potential Effects of Bromonordiazepam

Bromonordiazepam can produce a range of effects depending on the dose, route of administration, and individual factors. Some of the potential effects of this compound include:

  1. Sedation - Bromonordiazepam can induce drowsiness and sedation, leading to decreased alertness and reaction time.
  2. Muscle Relaxation - This compound can cause muscle relaxation and relief from muscle spasms or tension.
  3. Anxiety Relief - Bromonordiazepam can reduce feelings of anxiety, fear, and apprehension.
  4. Anticonvulsant - Bromonordiazepam has anticonvulsant properties, meaning it can prevent or suppress seizures.
  5. Amnesia - High doses of Bromonordiazepam can cause amnesia or memory impairment.
  6. Euphoria - Bromonordiazepam can cause feelings of euphoria or well-being at higher doses, increasing the risk of misuse and addiction.

Product Mechanism

Bromonordiazepam works by enhancing the effects of GABA neurotransmitters in the brain. GABA receptors are located throughout the CNS and are involved in regulating neuronal activity. When activated, GABA receptors inhibit the activity of neurons, reducing excitability and producing a calming effect. Benzodiazepines like Bromonordiazepam bind to a specific site on the GABA receptor, increasing the affinity of GABA for the receptor and facilitating its inhibitory effects. This leads to a decrease in the firing rate of neurons, resulting in sedation, relaxation, and anxiety relief.

Safety and Side Effects

Bromonordiazepam is generally safe when used as prescribed by a healthcare provider. However, like other benzodiazepines, this compound can cause side effects, especially at higher doses or with long-term use. Some of the possible side effects of Bromonordiazepam include:

  1. Drowsiness
  2. Fatigue
  3. Impaired coordination
  4. Headache
  5. Nausea
  6. Dry mouth
  7. Confusion
  8. Memory impairment
  9. Depression
  10. Irritability

In addition, Bromonordiazepam can be habit-forming and lead to physical dependence if used for extended periods. Abruptly stopping this medication can cause withdrawal symptoms, including anxiety, agitation, tremors, and seizures.

Dosing Information

The appropriate dosage of Bromonordiazepam depends on several factors, such as age, body weight, medical condition, and response to treatment. This medication is available as oral tablets or capsules, and the usual starting dose for adults is 1-2 mg taken three times daily. The maximum recommended daily dose is 6-8 mg, divided into three doses. However, the dosage may need to be adjusted based on individual response and tolerance.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code